Metraipolis › archive › dc_dfe11c9421fd

MRI performance to identify clinically significant prostate cancer following focal cryo-ablation — Europe PMC PMID:41383882

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41383882
DOI
10.1002/bco2.70120
License (as archived)
solo-consultazione
Archived
2026-11-07T17:54:23.701Z
SHA-256 of the archived text
ec5ea01d278ac13be917a830b79877c220b1ff42e95ca8d8f349decc81aa3189
Stable URL of this page
https://metraipolis.com/documento/dc_dfe11c9421fd

How to cite

MRI performance to identify clinically significant prostate cancer following focal cryo-ablation — Europe PMC PMID:41383882 — Europe PMC (en), https://europepmc.org/article/MED/41383882 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dfe11c9421fd (Metraipolis archive dc_dfe11c9421fd, sha256 ec5ea01d278ac13be917a830b79877c220b1ff42e95ca8d8f349decc81aa3189)
BibTeX
@misc{dcdfe11c9421fd,
  title = {MRI performance to identify clinically significant prostate cancer following focal cryo-ablation — Europe PMC PMID:41383882},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41383882},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dfe11c9421fd; sha256 ec5ea01d278ac13be917a830b79877c220b1ff42e95ca8d8f349decc81aa3189},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41383882. Agents can read the archived copy with the MCP tool read_document.